KRUMEL CAROLINE J 4
4 · PDL BIOPHARMA, INC. · Filed May 25, 2011
Insider Transaction Report
Form 4
KRUMEL CAROLINE J
Vice President of Finance
Transactions
- Award
Common Stock
2011-05-23+4,583→ 4,583 total
Footnotes (1)
- [F1]The shares will vest on December 31, 2012, provided Ms. Krumel is continuously employed by the Company through such date. In the event Ms. Krumel is terminated by PDL without cause or resigns for good reason, the shares shall ratably accelerate and vest in proportion to the time lapsed during the vesting period. During the vesting period, Ms. Krumel has the right to vote the shares and will receive any dividends and other shareholder distributions paid by PDL. Such dividends and other distributions shall accumulate with interest and will vest and pay if and when the underlying shares vest.